Get the tools and support you need to best manage your eczema

  • This field is for validation purposes and should be left unchanged.

Research

Understanding AD’s impact to improve your quality of life People living with atopic dermatitis (AD), the most common and chronic form of eczema, know first-hand the burden AD has on both individuals and families. The impacts reach far beyond the serious effects of the disease symptoms such as itch, pain, and inflammation –they also include […]

Read More


We asked, you answered. The verdict? People living with eczema want more information and more options. This past January, many of you responded to a 6-question online survey to evaluate patient satisfaction and the role of doctors in the treatment of the most serious form of eczema, atopic dermatitis (AD). We learned that the vast majority of […]

Read More


June 9, 2016 – On Monday, June 6, 2016 the pharmaceutical companies Regeneron and Sanofi, reported positive results for the Phase 3 the clinical trial of the new biologic drug, dupilumab, when used in conjunction with a topical corticosteroid by adults to treat moderate-to-severe atopic dermatitis (AD).

Read More


May 20, 2016 – Atopic dermatitis (AD) is associated with chronic itch, allergic disease and sleep disturbance, all of which might increase the risk of attention deficit (hyperactivity) disorder (ADD/ADHD).

Read More


May 2, 2016 – In the study, the research team, comprised of veterinary dermatologists, microbiologists, pathologists, and primary scientists, tracked the bacterial populations, or “microbiomes,” on dogs’ skin, and key properties of the skin’s barrier function during an occurrence of AD, and again after standard treatment with antibiotics.

Read More


April 21, 2016 – United States adults with AD have significantly impaired sleep and fatigue affecting IADLs (instrumental activity of daily living), and sleep disturbances may be under-diagnosed in this population.

Read More


February 29, 2016 – Early weaning, defined as the introduction of solid foods at 4 or 5 months of age, was inversely related to the risk of AD, with children weaned at 4 months having lower AD risk compared to those exclusively breastfed.

Read More


February 23, 2016 – The increased susceptibility of AD patients to skin and soft tissue infections with Staphylococcus aureus makes this an important topic to review with AD patients and their families. The importance of this topic is further underscored by the continued rise of MRSA and other antibiotic resistant bacteria.

Read More


February 22, 2016 – This study compares bleach baths with water baths on skin barrier function in atopic dermatitis using a split-body method as control. Neither bleach baths nor tap water baths were shown to disrupt barrier function.

Read More


February 16, 2016 – Epidermal barrier impairment and altered immune system in atopic dermatitis (AD) may predispose to ultraviolet induced DNA damage.

Read More